Zelalem Eshete

Array ( [id] => 6296788 [patent_doc_number] => 20100160628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid' [patent_app_type] => utility [patent_app_number] => 12/655087 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3875 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160628.pdf [firstpage_image] =>[orig_patent_app_number] => 12655087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5937640 [patent_doc_number] => 20110212983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'PLATELET ADP RECEPTOR INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/642379 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7676 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212983.pdf [firstpage_image] =>[orig_patent_app_number] => 12642379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778601 [patent_doc_number] => 20120041019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'PROTEASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/139503 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26764 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20120041019.pdf [firstpage_image] =>[orig_patent_app_number] => 13139503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8063623 [patent_doc_number] => 20110245209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'PYRIDOPYRIMIDINE DERIVATIVES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/139912 [patent_app_country] => US [patent_app_date] => 2009-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18965 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245209.pdf [firstpage_image] =>[orig_patent_app_number] => 13139912 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8968695 [patent_doc_number] => 08507505 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-08-13 [patent_title] => 'Dihydropyrazolopyrimidinone derivative' [patent_app_type] => utility [patent_app_number] => 13/133673 [patent_app_country] => US [patent_app_date] => 2009-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33982 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430298 [patent_doc_number] => 20100143301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'MODULATORS OF TOLL-LIKE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/632194 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68918 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143301.pdf [firstpage_image] =>[orig_patent_app_number] => 12632194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6424577 [patent_doc_number] => 20100168082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'Heterobicyclic Carboxamides as inhibitors for kinases' [patent_app_type] => utility [patent_app_number] => 12/632396 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 128473 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168082.pdf [firstpage_image] =>[orig_patent_app_number] => 12632396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7744396 [patent_doc_number] => 20120022044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'TRIAZOLE DERIVATIVES FOR TREATMENT OF ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 13/139830 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23100 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022044.pdf [firstpage_image] =>[orig_patent_app_number] => 13139830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619233 [patent_doc_number] => 07998952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Thiolactams and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/631144 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39074 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/998/07998952.pdf [firstpage_image] =>[orig_patent_app_number] => 12631144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6378415 [patent_doc_number] => 20100081682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => '39-Desmethoxy Derivatives of Rapamycin' [patent_app_type] => utility [patent_app_number] => 12/630251 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19978 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081682.pdf [firstpage_image] =>[orig_patent_app_number] => 12630251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6306953 [patent_doc_number] => 20100069373 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SUBSTITUTED LACTAMS AS INHIBITORS OF A BETA PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/615799 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35045 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20100069373.pdf [firstpage_image] =>[orig_patent_app_number] => 12615799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4456354 [patent_doc_number] => 07893079 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Substituted monocyclic CGRP receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/614726 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 58615 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/893/07893079.pdf [firstpage_image] =>[orig_patent_app_number] => 12614726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8446320 [patent_doc_number] => 08288373 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-16 [patent_title] => 'Modulators of CXCR7' [patent_app_type] => utility [patent_app_number] => 12/612638 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 28799 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12612638 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433081 [patent_doc_number] => 20100152267 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'NOVEL RIFAMYCIN 3,4-(3-SUBSTITUTED AMINOMETHYL) FUSED PYRROLO DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/611316 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10885 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152267.pdf [firstpage_image] =>[orig_patent_app_number] => 12611316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320754 [patent_doc_number] => 20100113425 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'PYRROLOBENZODIAZEPINES' [patent_app_type] => utility [patent_app_number] => 12/610478 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 26595 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113425.pdf [firstpage_image] =>[orig_patent_app_number] => 12610478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561781 [patent_doc_number] => 20110275614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'METHODS FOR THE PREPARATION OF IVABRADINE SULFATE AND FORM I CRYSTAL THEREOF' [patent_app_type] => utility [patent_app_number] => 13/144287 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2262 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275614.pdf [firstpage_image] =>[orig_patent_app_number] => 13144287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561781 [patent_doc_number] => 20110275614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'METHODS FOR THE PREPARATION OF IVABRADINE SULFATE AND FORM I CRYSTAL THEREOF' [patent_app_type] => utility [patent_app_number] => 13/144287 [patent_app_country] => US [patent_app_date] => 2009-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2262 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275614.pdf [firstpage_image] =>[orig_patent_app_number] => 13144287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314804 [patent_doc_number] => 20100112051 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'TIANEPTINE SULFATE SALT FORMS AND METHODS OF MAKING AND USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/604977 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 21055 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112051.pdf [firstpage_image] =>[orig_patent_app_number] => 12604977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4460908 [patent_doc_number] => 07879842 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-01 [patent_title] => 'Beta-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it' [patent_app_type] => utility [patent_app_number] => 12/589283 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1545 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/879/07879842.pdf [firstpage_image] =>[orig_patent_app_number] => 12589283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6478099 [patent_doc_number] => 20100041639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'CYCLIC MALONAMIDES AS INHIBITORS OF A BETA PROTEIN PRODUCTION' [patent_app_type] => utility [patent_app_number] => 12/603186 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42742 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20100041639.pdf [firstpage_image] =>[orig_patent_app_number] => 12603186 [rel_patent_id] =>[rel_patent_doc_number] =>)